[HTML][HTML] Changes in Lymphocyte Subpopulations after Remdesivir Therapy for COVID-19: A Brief Report
R Cianci, MG Massaro, E De Santis, B Totti… - International Journal of …, 2023 - mdpi.com
Remdesivir (RDV) has demonstrated clinical benefit in hospitalized COronaVIrus Disease
(COVID)-19 patients. The objective of this brief report was to assess a possible correlation …
(COVID)-19 patients. The objective of this brief report was to assess a possible correlation …
Changes in Lymphocyte Subpopulations after Remdesivir Therapy for COVID-19: A Brief Report.
R Cianci, MG Massaro, E De Santis… - International …, 2023 - search.ebscohost.com
Remdesivir (RDV) has demonstrated clinical benefit in hospitalized COronaVIrus Disease
(COVID)-19 patients. The objective of this brief report was to assess a possible correlation …
(COVID)-19 patients. The objective of this brief report was to assess a possible correlation …
Changes in Lymphocyte Subpopulations after Remdesivir Therapy for COVID-19: A Brief Report
R Cianci, MG Massaro, E De Santis, B Totti… - International Journal of …, 2023 - agris.fao.org
Remdesivir (RDV) has demonstrated clinical benefit in hospitalized COronaVIrus Disease
(COVID)-19 patients. The objective of this brief report was to assess a possible correlation …
(COVID)-19 patients. The objective of this brief report was to assess a possible correlation …
[HTML][HTML] Changes in Lymphocyte Subpopulations after Remdesivir Therapy for COVID-19: A Brief Report
R Cianci, MG Massaro, E De Santis, B Totti… - … Journal of Molecular …, 2023 - ncbi.nlm.nih.gov
Remdesivir (RDV) has demonstrated clinical benefit in hospitalized COronaVIrus Disease
(COVID)-19 patients. The objective of this brief report was to assess a possible correlation …
(COVID)-19 patients. The objective of this brief report was to assess a possible correlation …
Changes in lymphocyte subpopulations after remdesivir therapy for COVID-19: a brief report.
R Cianci, MG Massaro, E de Santis, B Totti… - 2023 - cabidigitallibrary.org
Remdesivir (RDV) has demonstrated clinical benefit in hospitalized COronaVIrus Disease
(COVID)-19 patients. The objective of this brief report was to assess a possible correlation …
(COVID)-19 patients. The objective of this brief report was to assess a possible correlation …
Changes in Lymphocyte Subpopulations after Remdesivir Therapy for COVID-19: A Brief Report
R Cianci, MG Massaro, E De Santis… - International …, 2023 - pubmed.ncbi.nlm.nih.gov
Remdesivir (RDV) has demonstrated clinical benefit in hospitalized COronaVIrus Disease
(COVID)-19 patients. The objective of this brief report was to assess a possible correlation …
(COVID)-19 patients. The objective of this brief report was to assess a possible correlation …
[HTML][HTML] Changes in Lymphocyte Subpopulations after Remdesivir Therapy for COVID-19: A Brief Report
R Cianci, MG Massaro, E De Santis… - International …, 2023 - search.proquest.com
Remdesivir (RDV) has demonstrated clinical benefit in hospitalized COronaVIrus Disease
(COVID)-19 patients. The objective of this brief report was to assess a possible correlation …
(COVID)-19 patients. The objective of this brief report was to assess a possible correlation …
Changes in Lymphocyte Subpopulations after Remdesivir Therapy for COVID-19: A Brief Report.
R Cianci, MG Massaro, E De Santis, B Totti… - … Journal of Molecular …, 2023 - europepmc.org
Remdesivir (RDV) has demonstrated clinical benefit in hospitalized COronaVIrus Disease
(COVID)-19 patients. The objective of this brief report was to assess a possible correlation …
(COVID)-19 patients. The objective of this brief report was to assess a possible correlation …